Publications by authors named "Thomas J Gibson"

Objectives: When identified prenatally, the imaging triad of asymmetric ventriculomegaly, interhemispheric cyst, and dysgenesis of the corpus callosum (AVID) can indicate a more serious congenital brain anomaly. In this follow-up series of 15 fetuses, we present the neurodevelopmental outcomes of a single institution cohort of children diagnosed prenatally with AVID.

Methods: Our fetal ultrasound database was queried for cases of AVID between 2000 and 2016.

View Article and Find Full Text PDF

Biocompatible antibody-nanoparticle conjugates have attracted interest as anticancer agents due to their potential to selectively target therapeutic agents at disease sites. However, new formulation and conjugation approaches are urgently needed to improve their uniformity for clinical applications. Here, a pH-responsive benzaldehyde-functionalized poly[oligo(ethylene glycol) methacrylate--formyl phenyl methacrylate]--poly[2-(diisopropyl)aminoethyl methacrylate] [P(OEGMA--pFPMA)--PDPA] block copolymer, prepared by reversible addition-fragmentation chain transfer polymerization, produced PEGylated nanoparticles (pH ∼ 7.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Thomas J Gibson"

  • Thomas J Gibson's research primarily focuses on prenatal diagnosis and its implications, particularly related to complex congenital brain anomalies such as asymmetric ventriculomegaly, interhemispheric cyst, and callosal dysgenesis (AVID).
  • His study on AVID underscores the importance of prenatal imaging in predicting serious neurodevelopmental outcomes, using data from 15 cases followed up post-diagnosis.
  • In addition to prenatal research, Gibson is also exploring advanced cancer therapy techniques using antibody-functionalized nanoparticles, aiming to enhance the efficacy and targeting of treatments for conditions like cancer through improved biocompatibility and responsiveness to pH levels.